PBMCs: Applications in Research

Peripheral blood mononuclear cells (abbreviated as PBMCs) are all of the cells in peripheral blood that contain a single, rounded nucleus. This group of cells is currently being used for various research applications.

Example application of PMBCs: CAR-T cell therapy. An illustration by Alpha Tauri 3D Graphics

Example application of PMBCs: CAR-T cell therapy. An illustration by Alpha Tauri 3D Graphics.

Regenerative therapy

Since the discovery of stem cells, PBMCs have been found to have several origins - including hematopoietic stem cells (HSCs), endothelial progenitor cells (EPCs), mesenchymal stem cells (MSCs), circulating fibroblasts, and mesenchymal stem cells.

The presence of these different populations of stem cells suggests that PBMCs could differentiate into several lineages in different microenvironments. More specifically, there is evidence that PBMCs could differentiate into blood cells, endothelial cells, hepatocytes, muscle cells, bone, epithelial cells, neural cells, and myofibroblasts.

In addition, scientists have even managed to transform PBMCs into induced pluripotent cells (iPSCs). Although the potential of PBMCs has been displayed, the mechanisms behind such protean differential potential of PBMCs is still unclear.

Transplantation and cell therapy

Since PBMCs can be isolated in a non-invasive manner compared to bone marrow stem cells, the extraction process can be done without the use of general anesthesia. In addition, autologous transplantation of PBMCs does not entail long-term immunosuppressive treatments or ethical considerations.

PBMC transplantation is currently used to treat individuals with hematological malignancies. However, further research will still be required to understand their differentiation potential and transplantability.

Diagnosing autoimmune diseases

Establishing a diagnosis of an autoimmune disease entails collecting and studying biopsies of the synovium, brain, and skin. However, this method cannot be applied to study the early stages of disease progression which may be most amenable to therapeutic interventions.

PBMCs provide several advantages over a biopsy; they can be extracted easily in a non-invasive manner and have the potential to discover pathogenic factors present in the blood. One disadvantage is the small amount of ribonucleic acid (RNA) that can be obtained from PBMCs, meaning a large number of cells may be required to generate usable data.

CAR-T cell therapy

CAR-T cell therapy has been considered a breakthrough approach due to its success observed in clinical trials with patients. In this method, a patient's own T cells are genetically engineered to express a chimeric antigen receptor (CAR). These cells then recognize antigens independently from MHCs and kill tumor cells when they encounter antigens.

CAR-T cells can also self-amplify in the host environment. The T cells used in this technique are derived from PBMCs. However, initially, T cells are isolated from an unfractionated population of PBMCs, which leads to cell populations that are a mixture of T cells and other PBMC cells.

This can lower the proliferation potential of isolated T cells. Later on, other processes are employed that enrich the T cell population from PBMCs by using a T cell-specific marker, although the ratio of CD4 to CD8 cells is still variable.

Additionally, the number of CD4 and CD8 cells can be controlled to produce a more consistent population of cells. However, the effects of changes in the ratio of CD4:CD8 on the clonal efficiency of CAR T cells is still unclear.

A path towards identifying biomarkers?

Recent studies have shown that PBMCs can act as a potential source of biomarkers. The increase or decrease in the mRNA profile of genes in PBMC can depict the status of several diseases - including diet-related metabolic changes and chronic diseases such as arthritis, lateral sclerosis, etc.

Despite the potential for use in research, the use of PBMCs also presents several challenges, especially considering the fact that PBMCs also possess several cell types with variable numbers between patients.

Further Reading

Last Updated: Jan 7, 2019

Dr. Surat P

Written by

Dr. Surat P

Dr. Surat graduated with a Ph.D. in Cell Biology and Mechanobiology from the Tata Institute of Fundamental Research (Mumbai, India) in 2016. Prior to her Ph.D., Surat studied for a Bachelor of Science (B.Sc.) degree in Zoology, during which she was the recipient of an Indian Academy of Sciences Summer Fellowship to study the proteins involved in AIDs. She produces feature articles on a wide range of topics, such as medical ethics, data manipulation, pseudoscience and superstition, education, and human evolution. She is passionate about science communication and writes articles covering all areas of the life sciences.  


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    P, Surat. (2019, January 07). PBMCs: Applications in Research. News-Medical. Retrieved on July 19, 2024 from https://www.news-medical.net/life-sciences/PBMCs-Applications-in-Research.aspx.

  • MLA

    P, Surat. "PBMCs: Applications in Research". News-Medical. 19 July 2024. <https://www.news-medical.net/life-sciences/PBMCs-Applications-in-Research.aspx>.

  • Chicago

    P, Surat. "PBMCs: Applications in Research". News-Medical. https://www.news-medical.net/life-sciences/PBMCs-Applications-in-Research.aspx. (accessed July 19, 2024).

  • Harvard

    P, Surat. 2019. PBMCs: Applications in Research. News-Medical, viewed 19 July 2024, https://www.news-medical.net/life-sciences/PBMCs-Applications-in-Research.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study uncovers how OTX2 drives aggressive childhood brain cancer